COVID-19

Dr. Todd Hutton gives tips for how to best handle the ongoing mental health crisis.

New data show NSAIDs treatment not associated with worse in-hospital mortality rates compared to patients not treated with NSAIDs.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.

New data show rheumatoid arthritis and immunosuppressive treatment associated with more severe risks of COVID-19, including hospitalization and death.

The companies announce plans to submit a Biologics License Agreement for the mRNA-based vaccine.

New data show immunosuppressant treatment did not increase susceptibility to or severity of COVID-19 in patients with immune-mediated inflammatory disease

Patients with nAMD, DME, and RVO received fewer intravitreal injections between pre- and post-lockdown periods.

Nearly a third of the US population has been fully vaccinated.

Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.

The US will send unused vaccines to India to help combat the growing pandemic.

Esther Freeman, MD, PhD, discusses the most frequent cutaneous presentations associated with vaccination.

A study out of Boston observes little to no difference in previous biologic prescription and worsened odds of infection nor death during the pandemic.

Esther Freeman, MD, PhD, talks about the various levels of dermatologic severity associated with COVID-19.

COVID-19 patients receiving at least 2 antibiotics were at a higher CDI risk.

Dr. Jennifer Payne discusses how the events of the last year has impacted her patients and what needs to happen to improve mental health care in the future.

Dr. Anthony Fauci believes the Johnson & Johnson vaccine pause will soon end.

An expert discusses the continued need to clarify COVID-19-related thrombosis risks as well as ensuring patients receive the most accurate information.

Maria DeSancho, MD, talks personal experiences with patients, vaccine hesitancy, mRNA versus adenovirus technology, risks and types of thrombosis, and more.

A thrombosis expert details cerebral venous thrombosis, the side effect reported in a half-dozen women administered the Johnson & Johnson vaccine.

FDA, CDC recommended halting use of the one-shot vaccine at all federal sites.

Cases continue to surge across the globe in several countries including India and Pakistan.

Some exposed newborns with negative PCR assays presented with fundus abnormalities.

The majority of diagnostic categories were common in COVID-19 patients than it was in patients with influenza.

A new study finds ambulatory telemedicine visits were exceptionally greater among minority communities through the pandemic.

A new analysis suggests the country experienced 23% more deaths than anticipated during the first year of the pandemic.

Older children seem to be at higher risk for myocarditis and pneumonia.

Outbreaks continue around the world, including over 100,000 daily cases reported in India.

Changes have been made to managing acute severe ulcerative colitis during COVID-19, including intravenous steroids, rescue therapy, and surgical approaches.

The companies hope the mRNA vaccine will become the first to be granted full FDA approval.

Mortality rates were similar in COVID-19 patients with and without chronic inflammatory diseases.